Boston Children's Hospital

NeuCyte Licenses Its Novel Neuronal Programming Technology to Enable Academic Research

Retrieved on: 
Monday, December 3, 2018

As part of the agreement, Boston Children's has obtained a non-exclusive license from NeuCyte to manufacture transcription factor Ngn2 programmed induced neurons.

Key Points: 
  • As part of the agreement, Boston Children's has obtained a non-exclusive license from NeuCyte to manufacture transcription factor Ngn2 programmed induced neurons.
  • The hospital intends to use this technology for internal research, teaching and educational purposes, and to perform services to other academic institutions.
  • "NeuCyte has the exclusive rights to Stanford's original neuronal induction technology and has further developed it to incorporate intoour proprietary in vitro drug discovery platforms," said Jonathan Davila, PhD, Co-founder and CEO of NeuCyte.
  • "We are happy to get the technology into the hands of Boston Children's Hospital where it can be further used for academic research.

Buoy Health Partners With Boston Children's Hospital To Improve The Way Parents Currently Assess Their Children's Symptoms Online

Retrieved on: 
Wednesday, August 8, 2018

We are proud to be working with this world-class institution to further our mission of building technology with heart for the health of every person."

Key Points: 
  • We are proud to be working with this world-class institution to further our mission of building technology with heart for the health of every person."
  • As Buoy's first innovation partner, Boston Children's hospital will aid Buoy in improving its pediatric capabilities.
  • Currently, parents concerned about their children's symptoms gain advice from Buoy by visiting its home page, www.buoyhealth.com .
  • Founded as a 20-bed hospital for children, Boston Children's is now a 415-bed comprehensive center for pediatric and adolescent health care.

US News & World Report ranks Cohen Children's Medical Center among nation's best in eight pediatric specialties

Retrieved on: 
Tuesday, June 26, 2018

To view US News & World Report's "Best Children's Hospitals" edition, go to:

Key Points: 
  • To view US News & World Report's "Best Children's Hospitals" edition, go to:
    Founded in 1983, Cohen Children's Medical Center is a 202-bed hospital dedicated exclusively to the care ofchildren.
  • The specialists in the hospital's national and international programs cover an entire range of specialties.
  • State-of-the-art care for children's medical, surgical, and dental needs are provided in both inpatient and outpatient settings.
  • For the 12th consecutive year in 2018, Cohen's was ranked among the nation's best children's hospitals in U.S. News & World Report's 2018-19 "America's Best Children's Hospitals" survey, achieving top-50 rankings in eight of 10 pediatric specialties.

Boston Children's Hospital ranked #1 in the nation

Retrieved on: 
Tuesday, June 26, 2018

BOSTON, June 26, 2018 /PRNewswire-USNewswire/ -- Boston Children's Hospital is the number one pediatric hospital in the nation according to U.S. News & World Report's 2018-19 Best Children's Hospitals Honor Roll.

Key Points: 
  • BOSTON, June 26, 2018 /PRNewswire-USNewswire/ -- Boston Children's Hospital is the number one pediatric hospital in the nation according to U.S. News & World Report's 2018-19 Best Children's Hospitals Honor Roll.
  • Boston Children's, home to more than 3,000 scientists, is also home to the world's largest research enterprise based at a pediatric hospital, currently ranking fourth in NIH funding among all independent hospitals.
  • "At Boston Children's, research and innovation are at the forefront of our patient care," says Kevin B. Churchwell, EVP of Health Affairs and COO.
  • Founded as a 20-bed hospital for children, Boston Children's is now a 415-bed comprehensive center for pediatric and adolescent health care.

Institute for Protein Innovation Relocates in Boston's Longwood Medical Area

Retrieved on: 
Monday, May 21, 2018

The 12,000-square-foot lab space represents a dramatic expansion and cements IPI's foothold in the Longwood biomedical hub for the foreseeable future.

Key Points: 
  • The 12,000-square-foot lab space represents a dramatic expansion and cements IPI's foothold in the Longwood biomedical hub for the foreseeable future.
  • "Institute for Protein Innovation has been a welcome addition to the Longwood Medical Area, which is home to world-class researchers at Harvard Medical School and four of our affiliated hospitalsBoston Children's Hospital, Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Dana-Farber Cancer Institute and Merck," said George Daley, dean of Harvard Medical School.
  • "We are committed to cultivating collaboration with our neighbors and will support IPI in enhancing the protein science research landscape in Longwood Medical Area and beyond."
  • IPI is a non-profit research organization whose mission is to foster innovation in protein research and bridge the missing link between genomics and therapeutics.